Literature DB >> 24891615

Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells.

Anjum Zafar1, Fan Wu1, Kristine Hardy1, Jasmine Li1, Wen Juan Tu1, Robert McCuaig1, Janelle Harris2, Kum Kum Khanna2, Joanne Attema3, Philip A Gregory3, Gregory J Goodall4, Kirsti Harrington5, Jane E Dahlstrom6, Tara Boulding1, Rebecca Madden1, Abel Tan1, Peter J Milburn7, Sudha Rao8.   

Abstract

Epithelial to mesenchymal transition (EMT) is activated during cancer invasion and metastasis, enriches for cancer stem cells (CSCs), and contributes to therapeutic resistance and disease recurrence. Signal transduction kinases play a pivotal role as chromatin-anchored proteins in eukaryotes. Here we report for the first time that protein kinase C-theta (PKC-θ) promotes EMT by acting as a critical chromatin-anchored switch for inducible genes via transforming growth factor β (TGF-β) and the key inflammatory regulatory protein NF-κB. Chromatinized PKC-θ exists as an active transcription complex and is required to establish a permissive chromatin state at signature EMT genes. Genome-wide analysis identifies a unique cohort of inducible PKC-θ-sensitive genes that are directly tethered to PKC-θ in the mesenchymal state. Collectively, we show that cross talk between signaling kinases and chromatin is critical for eliciting inducible transcriptional programs that drive mesenchymal differentiation and CSC formation, providing novel mechanisms to target using epigenetic therapy in breast cancer.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24891615      PMCID: PMC4135602          DOI: 10.1128/MCB.01693-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  96 in total

1.  c-Rel is required for chromatin remodeling across the IL-2 gene promoter.

Authors:  Sudha Rao; Steve Gerondakis; Donna Woltring; M Frances Shannon
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

2.  Role of DeltaNp63gamma in epithelial to mesenchymal transition.

Authors:  Jaime Lindsay; Simon S McDade; Adam Pickard; Karen D McCloskey; Dennis J McCance
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

3.  Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.

Authors:  Wai Leong Tam; Haihui Lu; Joyce Buikhuisen; Boon Seng Soh; Elgene Lim; Ferenc Reinhardt; Zhenhua Jeremy Wu; Jordan A Krall; Brian Bierie; Wenjun Guo; Xi Chen; Xiaole Shirley Liu; Myles Brown; Bing Lim; Robert A Weinberg
Journal:  Cancer Cell       Date:  2013-09-09       Impact factor: 31.743

4.  Protein kinase C-theta mediates negative feedback on regulatory T cell function.

Authors:  Alexandra Zanin-Zhorov; Yi Ding; Sudha Kumari; Mukundan Attur; Keli L Hippen; Maryanne Brown; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

Review 5.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

6.  Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes.

Authors:  Elissa L Sutcliffe; Karen L Bunting; Yi Qing He; Jasmine Li; Chansavath Phetsouphanh; Nabila Seddiki; Anjum Zafar; Elizabeth J Hindmarsh; Christopher R Parish; Anthony D Kelleher; Russell L McInnes; Toshiki Taya; Peter J Milburn; Sudha Rao
Journal:  Mol Cell       Date:  2011-03-18       Impact factor: 17.970

7.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

8.  Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.

Authors:  Chia-Wei Li; Weiya Xia; Longfei Huo; Seung-Oe Lim; Yun Wu; Jennifer L Hsu; Chi-Hong Chao; Hirohito Yamaguchi; Neng-Kai Yang; Qingqing Ding; Yan Wang; Yun-Ju Lai; Adam M LaBaff; Ting-Jung Wu; Been-Ren Lin; Muh-Hwa Yang; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2012-01-17       Impact factor: 12.701

9.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.

Authors:  Gang Wei; Lai Wei; Jinfang Zhu; Chongzhi Zang; Jane Hu-Li; Zhengju Yao; Kairong Cui; Yuka Kanno; Tae-Young Roh; Wendy T Watford; Dustin E Schones; Weiqun Peng; Hong-Wei Sun; William E Paul; John J O'Shea; Keji Zhao
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

10.  A functional Notch-survivin gene signature in basal breast cancer.

Authors:  Connie W Lee; Karl Simin; Qin Liu; Janet Plescia; Minakshi Guha; Ashraf Khan; Chung-Cheng Hsieh; Dario C Altieri
Journal:  Breast Cancer Res       Date:  2008-11-24       Impact factor: 6.466

View more
  19 in total

Review 1.  Protein kinase C in the immune system: from signalling to chromatin regulation.

Authors:  Pek Siew Lim; Christopher Ray Sutton; Sudha Rao
Journal:  Immunology       Date:  2015-10-06       Impact factor: 7.397

2.  A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED).

Authors:  Thiru Prasanna; Laeeq Malik; Robert D McCuaig; Wen Juan Tu; Fan Wu; Pek Siew Lim; Abel H Y Tan; Jane E Dahlstrom; Philip Clingan; Eugene Moylan; Jeremy Chrisp; David Fuller; Sudha Rao; Desmond Yip
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

3.  The role of protein kinase-C theta in control of epithelial to mesenchymal transition and cancer stem cell formation.

Authors:  Anjum Zafar; Kristine Hardy; Fan Wu; Jasmine Li; Sudha Rao
Journal:  Genom Data       Date:  2014-11-14

4.  Identification of chromatin accessibility domains in human breast cancer stem cells.

Authors:  K Hardy; F Wu; W Tu; A Zafar; T Boulding; R McCuaig; C R Sutton; A Theodoratos; S Rao
Journal:  Nucleus       Date:  2016-03-10       Impact factor: 4.197

5.  Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer.

Authors:  Tara Boulding; Fan Wu; Robert McCuaig; Jennifer Dunn; Christopher R Sutton; Kristine Hardy; Wenjuan Tu; Amanda Bullman; Desmond Yip; Jane E Dahlstrom; Sudha Rao
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

6.  LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.

Authors:  T Boulding; R D McCuaig; A Tan; K Hardy; F Wu; J Dunn; M Kalimutho; C R Sutton; J K Forwood; A G Bert; G J Goodall; L Malik; D Yip; J E Dahlstrom; A Zafar; K K Khanna; S Rao
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

Review 7.  The Role of PKC-θ in CD4+ T Cells and HIV Infection: To the Nucleus and Back Again.

Authors:  Chansavath Phetsouphanh; Anthony D Kelleher
Journal:  Front Immunol       Date:  2015-07-30       Impact factor: 7.561

8.  Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4+ T cells through p65 and H2B phosphorylation.

Authors:  Jasmine Li; Kristine Hardy; Chan Phetsouphanh; Wen Juan Tu; Elissa L Sutcliffe; Robert McCuaig; Christopher R Sutton; Anjum Zafar; C Mee Ling Munier; John J Zaunders; Yin Xu; Angelo Theodoratos; Abel Tan; Pek Siew Lim; Tobias Knaute; Antonia Masch; Johannes Zerweck; Vedran Brezar; Peter J Milburn; Jenny Dunn; Marco G Casarotto; Stephen J Turner; Nabila Seddiki; Anthony D Kelleher; Sudha Rao
Journal:  J Cell Sci       Date:  2016-05-05       Impact factor: 5.285

9.  Identification of miR-34a-target interactions by a combined network based and experimental approach.

Authors:  Martin Hart; Stefanie Rheinheimer; Petra Leidinger; Christina Backes; Jennifer Menegatti; Tobias Fehlmann; Friedrich Grässer; Andreas Keller; Eckart Meese
Journal:  Oncotarget       Date:  2016-06-07

10.  PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.

Authors:  Jessica Byerly; Gwyneth Halstead-Nussloch; Koichi Ito; Igor Katsyv; Hanna Y Irie
Journal:  Breast Cancer Res       Date:  2016-09-23       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.